Regeneron Pharmaceuticals (REGN)

Total Liabilities

$10.02B

Quarterly · Period ending: · USD

REGN logo

REGN Total Liabilities

Latest reported$10.02B
REGN Quarterly Total Liabilities ($13.20M → $10.02B)
High-resolution chart · PNG

REGN total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
10,019,000,000
9,445,200,000
9,301,800,000
9,211,600,000
8,280,300,000
8,157,600,000
8,405,800,000
8,116,000,000
7,881,000,000
7,378,500,000
7,107,100,000
7,258,900,000
6,639,600,000
6,564,700,000
6,550,500,000
6,239,000,000
6,518,000,000
6,434,000,000
6,666,000,000
6,413,500,000
6,358,600,000
5,795,200,000
6,138,000,000
5,958,500,000
5,371,300,000
3,624,500,000
3,715,500,000
3,434,900,000
3,417,700,000
3,410,100,000
2,977,200,000
2,937,313,000
2,765,554,000
2,805,052,000
2,620,208,000
2,649,622,000
2,585,635,000
2,951,344,000
2,524,221,000
2,336,772,000
2,128,400,000
2,139,378,000
1,954,295,000
1,886,048,000
1,188,512,000
1,227,143,000
1,329,502,000
1,187,631,000
1,087,236,000
1,049,148,000
998,937,000
950,244,000
884,922,000
869,650,000
835,105,000
854,591,000
862,843,000
846,135,000
837,851,000
554,778,000
568,830,000
556,202,000
561,617,000
594,369,000
419,425,000
400,885,000
344,440,000
319,749,000
331,839,000
271,101,000
251,186,000
388,958,000
400,228,000
470,273,000
475,991,000
421,699,000
418,522,000
404,742,000
368,466,000
292,713,000
294,565,000
299,766,000
309,499,000
282,894,000
281,888,000
284,508,000
290,565,000
293,812,000
298,044,000
302,072,000
341,912,000
344,299,000
257,704,000
264,826,000
245,593,000
237,804,000
227,292,000
229,381,000
229,042,000
23,742,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.